SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?


To: Manfred A. Wallner who wrote (3439)3/4/2000 7:36:00 PM
From: Bruce Cullen  Read Replies (2) | Respond to of 3702
 
TCLN is looking to have more serious movements, this company is on the radar screens of many investors.

TCLN has many potentially huge possible sources of revenues, their insight into cancer treatment should be more commended than it's present valuation shows.

See what Techniclone (TCLN) has going for it first hand,
http://www.geocities.com/treehopper/tcln_data.html

All best,

Bruce Cullen
SherwoodCoastsGroup.Com



To: Manfred A. Wallner who wrote (3439)3/5/2000 1:29:00 PM
From: shero  Read Replies (1) | Respond to of 3702
 
Manfred:

I can't tell you anything about Yahoo. Its been well over a year, maybe two since I've been at the Yahoo TCLN chat line. There was just too much....there.

It would be nice if there was more chat here, but I think most of the "old timers" have sold there positions. That's good and bad, we sure needed, and have new blood in this stock.

I think TCLN will make a new trading high this week. Whether we can make a new closing high remains to be seen, but it is very important from a technical point of view. If not the stock will remain in a trading range, buy under $7, sell wherever you want over that. I hope not but we'll see,

I expect an announcement on a licensing deal w/TNT. In December TCLN granted a 90 day "look-see". That 90 day period will expire this month. I don't see it as a big announce re money but it will start to establish credibility. And I expect to see more licensing deals in the future.

Regards, all--Shero